Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Niagen Bioscience, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
NAGE
Nasdaq
2830
www.niagenbioscience.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Niagen Bioscience, Inc.
Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research
- Jul 16th, 2026 6:32 am
Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)
- Jul 13th, 2026 6:32 am
Niagen Bioscience CEO Rob Fried to Participate in Virtual Fireside Chat to Discuss Pharmaceutical Strategy on July 15, 2026
- Jul 9th, 2026 6:32 am
Niagen Bioscience Launches Pharmaceutical Program for Accelerated Aging and Rare Genetic Diseases
- Jul 8th, 2026 6:32 am
Implied Volatility Surging for Niagen Bioscience Stock Options
- Jul 6th, 2026 9:15 am
Niagen Bioscience Inc. (NAGE) Renames Research Program Amid Focus in Advancing NAD+ Applications
- Jun 19th, 2026 12:20 pm
Niagen Bioscience (NAGE) Stock Sees Split Analyst Revisions As Price Targets Fall
- Jun 17th, 2026 7:12 am
Assessing Niagen Bioscience (NAGE) Valuation As It Renames Its NAD+ Research Program
- Jun 4th, 2026 9:14 pm
Niagen Bioscience to Present at the 16th Annual East Coast IDEAS Investor Conference
- Jun 3rd, 2026 6:34 am
How The Niagen Bioscience (NAGE) Investment Story Is Evolving Without New Analyst Signals
- Jun 2nd, 2026 9:10 am
Niagen Bioscience Renames ChromaDex External Research Program to the Niagen Research Program, Strengthening Position as the Global Leader in NAD+ Science
- Jun 2nd, 2026 6:32 am
3 Growth Companies With High Insider Ownership And 15% Revenue Growth
- May 22nd, 2026 5:35 am
How The Niagen Bioscience (NAGE) Story Is Shifting As Price Targets Edge Lower
- May 15th, 2026 6:21 pm
3 Promising Penny Stocks With Market Caps Over $70M
- May 15th, 2026 12:05 pm
Promising Penny Stocks To Consider In May 2026
- May 15th, 2026 6:05 am
Spotlight On Penny Stocks To Consider In May 2026
- May 14th, 2026 12:05 pm
May 2026's Promising Penny Stocks
- May 14th, 2026 6:04 am
Spotlight On Oramed Pharmaceuticals And Two Other Prominent Penny Stocks
- May 13th, 2026 6:05 am
Undervalued Penny Stocks Worth Watching In May 2026
- May 12th, 2026 12:05 pm
Creative Global Technology Holdings And 2 Other Promising Penny Stocks
- May 12th, 2026 6:04 am
Scroll